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UNITED STATES COURT OF APPEALS 
FOR THE THIRD CIRCUIT 
 
No. 98-6427 
 
BAYER AG, In re Application for an Order permitting 
BAYER AG to take discovery, pursuant to the Federal 
Rules of Civil Procedure, of BETACHEM, INC. for use in 
an action pending in the FIRST INSTANCE COURT 
NO. 25 of BARCELONA, SPAIN. 
 
       Appellant 
 
v. 
 
BETACHEM, INC. 
 
       Appellee 
 
APPEAL FROM THE 
UNITED STATES DISTRICT COURT 
FOR THE DISTRICT OF NEW JERSEY 
(D.C. No. 96-cv-05650) 
District Judge: William H. Walls 
 
ARGUED JANUARY 15, 1999 
 
BEFORE: NYGAARD, ALITO, and LEWIS, Circuit Judges. 
 
(Filed April 12, 1999) 
 
       Frederick L. Whitmer (Argued) 
       Pitney Harden Kipp & Szuch 
       PO Box 1945 
       Morristown, NJ 07962-1945 
 
        Attorney for Appellant 
 
 
  
       Dwight E Yellen (Argued) 
       Ballon, Stoll, Bader & Nadler 
       1450 Broadway 
       New York, NY 10018-2268 
 
        Attorney for Appellee 
 
OPINION OF THE COURT 
 
NYGAARD, Circuit Judge. 
 
Bayer AG appeals the District Court's denial of its motion 
seeking unredacted documents under 28 U.S.C. S 1782. 
Bayer contends that the unredacted information is 
necessary to (1) impeach the credibility of a witness in 
litigation pending in Spain, and (2) discover additional 
information concerning a drug master file at issue. 
Betachem responds that the information sought is beyond 
the scope of the subpoena, and alternatively, that Bayer 
already has the information sought, albeit in a different 
form. The District Court had jurisdiction under 28 U.S.C. 
SS 1131 and 1782. We have jurisdiction under 28 U.S.C. 
S 1291.1 We review the District Court's denial of a discovery 
request made under 28 U.S.C. S 1782 for an abuse of 
discretion. See In re Application Pursuant to 28 U.S.C. 
S 1782 for an Order Permitting Bayer AG to Take Discovery, 
146 F.3d 188, 191 (3d Cir. 1998) (hereinafter In re Bayer 
AG). We will affirm. 
 
I. 
 
The facts surrounding Bayer AG's original discovery 
request are amply set forth in In re Bayer AG, 146 F.3d at 
189-91, where we concluded that a district court abuses its 
discretion when it denies a section 1782 application for 
discovery based on its own determination that the material 
sought would not be discoverable or admissible in the 
_________________________________________________________________ 
 
1. Only the discovery dispute under 18 U.S.C.S 1782 is occurring in the 
United States. Therefore, because the underlying litigation is in Spain, 
this discovery order is immediately appealable. 
 
                                2 
  
foreign jurisdiction. Thus, we remanded the case to the 
District Court. 
 
Following our remand, Betachem produced approximately 
four hundred documents in response to the subpoena 
duces tecum. Despite a protective order issued by the 
District Court, Betachem produced the documents in 
redacted form. Betachem contends that the redacted 
information was "beyond the scope of the subpoena" and 
included references to "other drugs, the identity of 
customers or potential customers, prices, marketing 
strategies, marketing analyses, etc." SA 2. 
 
Bayer then requested unredacted versions of the 
documents. Betachem refused, but allowed independent 
patent counsel for Bayer to review the original unredacted 
documents at the law offices of Betachem's counsel. 
However, patent counsel was not allowed to make any 
notes. After the review, patent counsel requested 
production of approximately seventy documents in full 
unredacted form. Betachem produced thirty-five of the 
requested documents. 
 
After considering arguments from both counsel, the 
District Court concluded that the requested information 
was cumulative and that "the aims of discovery" were "more 
than met by the redacted information being furnished." AA 
63. Therefore, the District Court denied Bayer's request for 
the unredacted documents. Bayer now appeals and 
contends that the District Judge abused its limited 
discretion under 28 U.S.C. S 1782 by imposing upon Bayer, 
and the statute, requirements not enacted by Congress. 
 
II. 
 
First, we note that our previous decision did not imply 
that Bayer is entitled to all discovery sought. See In re 
Bayer AG, 146 F.3d at 196 ("Our discussion is not intended 
to suggest that Bayer is necessarily entitled to have its 
application granted. That determination will have to await 
the district court's proper exercise of its discretion on 
remand when it will be free to consider the relevance of 
factors not before us, such as the timeliness of Bayer's 
application and appropriate measures, if needed, to protect 
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the confidentiality of the materials."). Second, we also 
commented that "[t]he reference in S 1782 to the Federal 
Rules suggests that under ordinary circumstances the 
standards for discovery under those rules should also apply 
when discovery is sought under the statute." Id. at 195. The 
party opposing discovery has the "burden of demonstrating 
offense to the foreign jurisdiction, or any other facts 
warranting the denial of a particular application." Id. at 
196. 
 
Section 1782 states in relevant part: 
 
       the district court of the district in which a person 
       resides or is found may order him to give his testimony 
       or statement or to produce a document or other thing 
       for use in a proceeding in a foreign or international 
       tribunal . . . . The order may be made pursuant to a 
       letter rogatory issued, or request made, by a foreign or 
       international tribunal or upon the application of any 
       interested person . . . . To the extent that the order 
       does not prescribe otherwise, the testimony or 
       statement shall be taken, and the document or other 
       thing produced, in accordance with the Federal Rules 
       of Civil Procedure. 
 
28 U.S.C. S 1782(a). 
 
Congress enacted section 1782 to further the following 
goals: "facilitat[ing] the conduct of litigation in foreign 
tribunals, improv[ing] international cooperation in litigation, 
and put[ting] the United States into the leadership position 
among world nations." In re Bayer AG, 146 F.3d at 191-92. 
However, these goals do not in turn mean that a party in 
foreign litigation is entitled to unbridled and unlimited 
discovery under the statute. To the contrary, under the 
terms of the statute, the discovery process is generally 
guided by the Federal Rules of Civil Procedure. 
 
As we noted in In re Bayer AG, 146 F.3d at 195, "[t]he 
reference in S 1782 to the Federal Rules suggests that 
under ordinary circumstances the standards for discovery 
under those rules should also apply when discovery is 
sought under the statute." Moreover, "[t]he permissive 
language of section 1782 vests district courts with 
discretion to grant, limit, or deny discovery." In re 
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Metallgesellschaft AG, 121 F.3d 77, 79 (2d Cir. 1997). Thus, 
a district court should exercise its discretion while keeping 
in mind the aims of the statute. To that end, a district 
court may refuse to grant a discovery request, or may 
impose various conditions and protective orders attendant 
to the production of requested documents. See In re Bayer 
AG, 146 F.3d at 192. 
 
The applicable Federal Rules of Civil Procedure 
concerning discovery state in relevant part: 
 
       (1) In General. Parties may obtain discovery regarding 
       any matter, not privileged, which is relevant to the 
       subject matter involved in the pending action whether 
       it relates to the claim or defense of the party seeking 
       discovery or to the claim or defense of any other party, 
       including the existence, description, nature, custody, 
       condition and location of any books, documents, or 
       other tangible things and the identity and location of 
       persons having knowledge of any discoverable matter. 
       The information sought need not be admissible at the 
       trial if the information sought appears reasonably 
       calculated to lead to the discovery of admissible 
       evidence. 
 
       (2) Limitations . . . . The frequency or extent of use of 
       the discovery methods otherwise permitted under these 
       rules and by any local rule shall be limited by the court 
       if it determines that: (1) the discovery sought is 
       unreasonably cumulative or duplicative, or is 
       obtainable from some other source that is more 
       convenient, less burdensome or less expensive. 
 
Fed. R. Civ. P. 26(b)(1) & (2). 
 
Although the scope of discovery under the Federal Rules 
is unquestionably broad, this right is not unlimited and 
may be circumscribed. See Micro Motion, Inc. v. Kane Steel 
Co., 894 F.2d 1318, 1322 (Fed. Cir. 1990) (citing Hickman 
v. Taylor, 329 U.S. 495, 507, 67 S. Ct. 385, 391 (1947)). 
The Federal Rules of Civil Procedure expressly allow a 
district court to use its discretion and deny discovery 
requests if the material sought is "unreasonably 
cumulative." Fed. R. Civ. P. 26(b)(2). Here, the District 
Court examined some of the documents, listened to 
 
                                5 
  
arguments presented by counsel and concluded that 
unredacted versions of the documents desired would be 
"cumulative" and that Bayer already "discovered the gold" 
but refused to acknowledge it. AA 54, 58. During oral 
argument, counsel for Bayer stated that the only 
substantive redactions involved names of customers. 
 
Although patent counsel for Bayer was not allowed to 
take notes during his document review, counsel did spend 
several hours scrutinizing unredacted original documents 
which contained the names of Betachem's customers. SA 
34-40. Additionally, counsel for Bayer twice mentions by 
name in correspondence to the District Court the 
supposedly unknown customer AA 24, 27. Last, the 
Spanish interrogatories which were produced to Bayer in 
unredacted form with English translation contain the name 
of the unknown customers. SA 47-54. Despite Bayer's 
assertions, this conclusion by the District Court does not 
"improperly intrude . . . into the substantive role of the 
foreign forum court." Bayer Br. at 9. Likewise, the decision 
is not a prediction of the actions of the foreign tribunal. But 
cf. In re Bayer AG, 148 F.3d at 192 (commenting that "it 
`would contradict the express purpose of section 1782' if 
the American court were required to predict the actions of 
another country's tribunal" and finding that the District 
Court's requirement that requested discovery be 
discoverable in the foreign jurisdiction exceeded the proper 
scope of section 1782) (quoting John Deere Ltd. v. Sperry 
Corp., 754 F.2d 132, 136 (3d Cir. 1985)). Rather, the 
decision is fully within the discretion granted the District 
Court under the Federal Rules of Civil Procedure which are 
incorporated by reference into 28 U.S.C. S 1782. 
 
III. 
 
In summary, section 1782, entitled "Assistance to foreign 
and international tribunals and to litigation before such 
tribunals," incorporates by reference the scope of discovery 
permitted by the Federal Rules of Civil Procedure. See 28 
U.S.C. S 1782. Rule 26 of the Federal Rules of Civil 
Procedure expressly grants a district judge the authority to 
deny discovery when the information sought is 
"unreasonably cumulative." Fed. R. Civ. P. 26. Although the 
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information already obtained may not be in the form most 
desired by Bayer, we cannot say that the District Court 
abused its discretion by denying Bayer's request for certain 
unredacted documents. Accordingly, we will affirm the 
District Court's denial. 
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